Viridian Therapeutics unveiled solid results Tuesday for its experimental eye disease treatment, a potential rival to Amgen.

Tepezza (teprotumumab-trbw) is usually given as an infusion into your vein once every 3 weeks. A full course of treatment is 8 infusions, which takes about 5 months to complete. Tepezza’s dose is ...

Doses of Tepezza are given by an intravenous infusion through a blood vessel in your arm. This infusion is usually given at a hospital, health care provider’s office, or infusion center. Sometimes you ...

Because it's rare and not always top of mind for doctors, TED can quietly progress or be mistaken for allergies or Graves' ...

After Amgen completed its $27.8 billion buyout of Horizon Therapeutics in October, executives at the California biotech made it a priority to right the course of thyroid eye disease treatment ...

Living with a rare disease can often mean days upon months upon years of searching for answers. Unfortunately, this is the case for many who are living with Thyroid Eye Disease (TED) – a rare ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

Tepezza (teprotumumab-trbw) is a brand-name intravenous (IV) infusion for thyroid eye disease in adults. An IV infusion is an injection into a vein given over time. Some of Tepezza’s more common side ...

Tepezza is an intravenous medication that may help treat thyroid eye disease (TED) by addressing immune system activity behind the eyes. Possible side effects of Tepezza include hearing issues, ...